期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多发性骨髓瘤治疗中值得关注的几个问题 被引量：5

下载PDF
导出
摘要 多发性骨髓瘤(multiple myeloma,MM)的治疗主要包括传统化疗、自体造血干细胞移植(autologous stem cell transplantation,ASCT)和新型靶向治疗3种方式。新的靶向治疗的联合或与传统抗骨髓瘤药物的联合已经能够获得与ASCT相当的完全缓解(complete remission,CR)率,并可延长患者生存期。取得CR是长期控制疾病的关键,但仍有部分患者虽未取得CR,但生存期却可超过5年甚至10年。本文就CR在MM治疗中的临床意义以及ASCT的地位和作用进行综述。
作者 李勇华 侯健
机构地区 第二军医大学长征医院血液科 广州军区广州总医院血液科
出处 《肿瘤》 CAS CSCD 北大核心 2008年第11期1008-1011,共4页 Tumor
关键词 多发性骨髓瘤 治疗 自体干细胞移植 完全缓解
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1ATFAL M, HAROUSSEAU J L, STOPPA A M, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome[J]. N Engl J Med, 1996,335(2) :91-97.
  • 2BARLOGIE B, SHAUGHNESSY J, TRICOT G, et al. Treatment of multiple myeloma[ J]. Blood, 2004,103 ( 1 ) :20-32.
  • 3BARLOGIE B, KYLE R A, ANDERSON K C, et al. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase Ⅲ US Intergroup Trial S9321 [J]. J Clin Oncol, 2006,24(6) :929-936.
  • 4KYLE RA, LEONG T, LI S, et al. Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation [ J ]. Cancer, 2006,106(9) : 1958-1966.
  • 5PALUMBO A, BRINGHEN S, CARAVITA T, et al. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial [ J ]. Lancet, 2006,367 (9513) :825-831.
  • 6MATEOS M V, HERNANDEZ J M, HERNANDEZ M T, et al. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a muhicenter phase 1/2 study [ J ]. Blood, 2006,108 ( 7 ) :2165-2172.
  • 7NIESVIZKY R, RICHARDSON PG, SONNEVELD P, et al. Relationship between quality of response to Bortezomib and clinical benefit in multiple myeloma [ J ]. Blood, 2006,108 ( 11 ) : 1007 a.
  • 8RICHARDSON P G, SONNEVELD P, SCHUSTER M W, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma[J]. N Engl J Med, 2005,352(24) :2487-2498.
  • 9WEBER DM, CHEN C, NIESVIZKY R, et al. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America [J]. N Engl J Med, 2007,357(21 ) :2133-2142.
  • 10OIVANEN T M, KELLOKUMPU-LEHTINEN P, KOIVISTO A M, et al. Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish leukaemia group study[ J]. Eur J Haematol, 1999,62 (2) : 109-116.

同被引文献58

  • 1张方楹.多发性骨髓瘤治疗新进展[J].中外医疗,2008,27(27):12-17. 被引量：1
  • 2BLADE J, SAMSON D, REECE D, et al. Criteria for evaluating disease response and progression in patients with multiplemyeloma treated by high dose therapy and hemopoietic stem cell transplantation. Myeloma Subcommittee of the EMBT. European Group for Blood and Marrow Transplant [ J ]. Br J Haematol, 1998,102 (5) : 1115-1123.
  • 3FIELD-SMITH A, MORGAN G J, DAVIES F E. Bortezomib (Veleade^TM) in the treatment of multiple myeloma[J]. Ther Clin Risk Manag, 2006, 2 ( 3 ) :271-279.
  • 4ROODMAN G D. Bone building with bortezomib [ J ]. J Clin Invest, 2008, 118(2) :462-464.
  • 5SMITH M R. Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence [ J ]. Cancer Treat Rev, 2005, 31(3) :19-25.
  • 6YEH H S, BERENSON J R. Treatment for myeloma bone disease [ J ]. Clin Cancer Res,2006,12 (20) :6279-6284.
  • 7JAGANNATH S, BRIAN D, WOLF JL, et al. A phase 2 study of bortezomib as first-line therapy in patients with multiple myeloma [J]. Blood, 2004,104 : Abstract 333.
  • 8RICHARDSON P G, CHANAN-KHAN A, SCHLOSSMAN R L, et al. Phase Ⅱ trial of single agent bortezomib in patients with previously untreated multiple myeloma [ J ]. Blood, 2004, 104 : Abstract 336.
  • 9WU K L, VAN WIERINGEN W, VELLENGA E, et al. Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice[ J], Haematologica, 2005, 90 (7) :996-997.
  • 10Richardson PG, Anderson KC. Multiple myeloma. London: Remedica Publishing ,2004.64.

引证文献5

二级引证文献20

肿瘤
2008年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部